Dr. Harris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1365 Clifton Rd NE
Atlanta, GA 30322Phone+1 404-778-5000
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1998- Emory University School of MedicineResidency, Internal Medicine, 1988 - 1991
Loma Linda University School of MedicineClass of 1988
Certifications & Licensure
GA State Medical License 1991 - 2025
TN State Medical License 1991 - 1995- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Board of Trustees Loma Linda University Health, 2016
Clinical Trials
- 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer Start of enrollment: 2009 Jun 01
- A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer Start of enrollment: 2011 Sep 06
- PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Start of enrollment: 2012 Jun 12
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsRandomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasect...Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta K Pal, Michael R Pins
Journal of Clinical Oncology. 2024-06-10 - 1 citationsCombination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience.Dylan J Martini, T Anders Olsen, Subir Goyal, Yuan Liu, Sean T Evans
Journal of Immunotherapy and Precision Oncology. 2022-08-01 - 13 citationsMetastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials.Tony Zibo Zhuang, Katherine Case, Timothy Anders Olsen, Jacqueline T Brown, Bradley C Carthon
Cancers. 2022-06-10
Press Mentions
Prostate Cancer Risk Greatest in African American MenJanuary 24th, 2024
Professional Memberships
- Member
- Member
Other Languages
- Spanish, Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
